Regulators hit Wall Road banking institutions with $549 million in penalties for history-trying to keep failures

Regulators hit Wall Road banking institutions with 9 million in penalties for history-trying to keep failures


Crucial Points
  • U.S. regulators on Tuesday announced a combined $549 million in penalties from Wall Avenue corporations that failed to retain digital information of worker communications.
  • The Securities and Trade Fee announced expenses and $289 million in fines against 11 corporations for “common and longstanding failures” to keep records, together with by enabling workers to use unsupervised aspect channels such as messaging applications WhatsApp and Signal, the regulator said.
  • The Commodity Futures Trading Commission also said it fined 4 banks a whole of $260 million for failing to sustain information needed by the agency.



Supply

These underperforming groups may deliver AI-electric appeal. Here’s why.
Finance

These underperforming groups may deliver AI-electric appeal. Here’s why.

ETF Edge These underperforming groups may deliver AI-electric appeal. Here’s why. Published Sat, Nov 15 202511:00 AM EST Blair Bao WATCH LIVE Source

Read More
Warren Buffett’s Berkshire Hathaway reveals new position in Alphabet
Finance

Warren Buffett’s Berkshire Hathaway reveals new position in Alphabet

Warren Buffett speaks during the Berkshire Hathaway Annual Shareholders Meeting in Omaha, Nebraska on May 3, 2025. CNBC Warren Buffett’s Berkshire Hathaway revealed a new position in Alphabet, making the Google parent the conglomerate’s 10th largest equity holding at the end of September, according to a regulatory filing. Berkshire disclosed a $4.3 billion stake in […]

Read More
Stocks making the biggest moves midday: Whirlpool, Topgolf Callaway, Nvidia, Stubhub & more
Finance

Stocks making the biggest moves midday: Whirlpool, Topgolf Callaway, Nvidia, Stubhub & more

Check out the companies making the biggest moves midday: Scholar Rock — The Cambridge, Massachusetts-based biotech jumped 23% after saying it ” completed constructive and collaborative in-person Type A meeting ” with the FDA on Wednesday for a biologics license application for apitegromab, a spinal muscular atrophy treatment. Officials from Novo Nordisk’s Catalent Indiana joined […]

Read More